Format

Send to

Choose Destination
Prim Care. 2013 Mar;40(1):195-211. doi: 10.1016/j.pop.2012.11.003. Epub 2012 Dec 4.

Hyperlipidemia as a risk factor for cardiovascular disease.

Author information

1
Division of Endocrinology, Department of Family Medicine, Mayo College of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA. nelson.robert1@mayo.edu

Abstract

Elevated levels of blood lipids are well-documented risk factors for cardiovascular disease. Current classification schemes and treatment levels for hyperlipidemia are based on the National Cholesterol Education Panel's Adult Treatment Program-3 (ATP-III) guidelines. Extensive research over the past decade has raised the question whether or not ATP-III guidelines are sufficiently aggressive. New guidelines from ATP-IV are expected to be released in the near future, but in the meantime physicians are faced with uncertainty about how low to target low-density lipoprotein cholesterol, whether to pharmacologically treat high-density lipoprotein cholesterol and triglyceride levels, and how best to achieve target goals.

PMID:
23402469
PMCID:
PMC3572442
DOI:
10.1016/j.pop.2012.11.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center